NO975901L - Vinyl-pyrrolidinon cefalosporiner med basiske substituenter - Google Patents

Vinyl-pyrrolidinon cefalosporiner med basiske substituenter

Info

Publication number
NO975901L
NO975901L NO975901A NO975901A NO975901L NO 975901 L NO975901 L NO 975901L NO 975901 A NO975901 A NO 975901A NO 975901 A NO975901 A NO 975901A NO 975901 L NO975901 L NO 975901L
Authority
NO
Norway
Prior art keywords
formula
cephalosporins
compounds
vinyl pyrrolidinone
basic substituents
Prior art date
Application number
NO975901A
Other languages
English (en)
Norwegian (no)
Other versions
NO975901D0 (no
Inventor
Peter Angehrn
Paul Hebeisen
Ingrid Heinze-Krauss
Malcolm Page
Valurie Runtz
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO975901D0 publication Critical patent/NO975901D0/no
Publication of NO975901L publication Critical patent/NO975901L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/572—Five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Peptides Or Proteins (AREA)
NO975901A 1996-12-19 1997-12-16 Vinyl-pyrrolidinon cefalosporiner med basiske substituenter NO975901L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP96120472 1996-12-19
EP97119528 1997-11-07

Publications (2)

Publication Number Publication Date
NO975901D0 NO975901D0 (no) 1997-12-16
NO975901L true NO975901L (no) 1998-06-22

Family

ID=26142379

Family Applications (1)

Application Number Title Priority Date Filing Date
NO975901A NO975901L (no) 1996-12-19 1997-12-16 Vinyl-pyrrolidinon cefalosporiner med basiske substituenter

Country Status (20)

Country Link
US (1) US5981519A (de)
EP (1) EP0849269B9 (de)
JP (2) JP3264877B2 (de)
KR (3) KR100395985B1 (de)
CN (5) CN1104436C (de)
AT (1) ATE220402T1 (de)
AU (1) AU729653B2 (de)
CA (2) CA2628224C (de)
CY (1) CY2400B1 (de)
CZ (1) CZ405797A3 (de)
DE (1) DE69713865T2 (de)
DK (1) DK0849269T3 (de)
ES (1) ES2179996T3 (de)
HU (1) HUP9702474A3 (de)
IL (1) IL122604A0 (de)
MA (1) MA26457A1 (de)
NO (1) NO975901L (de)
NZ (1) NZ329363A (de)
PT (1) PT849269E (de)
TW (1) TW415949B (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5977381A (en) * 1998-01-12 1999-11-02 Hoffmann-La Roche Inc. Process for making 3-amino-pyrolidine derivatives
JP3872955B2 (ja) * 1998-06-15 2007-01-24 バジリア ファルマスーチカ アーゲー ３−（２−オキソ−〔１，３′〕ビピロリジニル−３−イリデンメチル）−セフェムの誘導体
US6232306B1 (en) * 1998-06-15 2001-05-15 Hoffmann-La Roche Inc. Derivatives of 3-(2-oxo-[1,3′]bipyrrolidinyl-3-ylidenemethyl)-cephams
AU1654900A (en) * 1998-12-03 2000-06-19 F. Hoffmann-La Roche Ag Bi-pyrrolidinylvinl (carba) cephalosporins
ATE370146T1 (de) * 1999-07-05 2007-09-15 Basilea Pharmaceutica Ag Verfahren zur herstellung von cephalosporin- derivaten
WO2001004127A1 (en) * 1999-07-07 2001-01-18 F. Hoffmann-La Roche Ag Vinylpyrrolidinone derivatives with substituted thiazole ring
ATE341642T1 (de) 2000-04-19 2006-10-15 Basilea Pharmaceutica Ag Verfahren zur herstellung von d- asparaginderivaten
US6504025B2 (en) * 2000-05-24 2003-01-07 Basilea Pharmaceutica Ag Process for the preparation of vinyl-pyrrolidinone cephalosporin derivatives
KR100698814B1 (ko) * 2000-08-14 2007-03-23 바실리어 파마슈티카 아게 Ｎ-보호-3-피롤리딘-락탐 치환 포스포늄염의 제조 방법
ITMI20012363A1 (it) * 2001-11-09 2003-05-09 Antibioticos Spa Metodo per la sintesi di catene laterali di cefalosporine
PL1606293T3 (pl) * 2003-03-27 2010-01-29 Basilea Pharmaceutica Ag Cefalosporyna w postaci krystalicznej
EP2308562B1 (de) * 2003-12-25 2015-02-25 Ono Pharmaceutical Co., Ltd. Azetidin-Ringverbindungen und diese enthaltende Arzneimittel
US7569691B2 (en) * 2005-04-20 2009-08-04 Shin-Etsu Chemical Co., Ltd. Protected piperazino group-bearing organoxysilane compound and making method
CN101245077B (zh) * 2007-02-14 2010-06-02 山东轩竹医药科技有限公司 头孢菌素衍生物
CN101245079B (zh) * 2007-02-14 2010-07-07 山东轩竹医药科技有限公司 头孢抗生素衍生物
EA201070504A1 (ru) 2007-10-25 2010-12-30 Эйкеоджен, Инк. КАРБАЦЕФЕМ β-ЛАКТАМОВЫЕ АНТИБИОТИКИ
AR071318A1 (es) 2008-04-15 2010-06-09 Basilea Pharmaceutica Ag Benzhidril ester del acido (6r,7r)-7-{2-(5-amino-[1,2,4]tiadiazol-3-il)-2-[(z)-tritiloxiimino]-acetilamino}-3-[(r)-1'-terc-butoxicarbonil-2-oxo-[1,3']bipirrolidinil-(3e)-ilidenometil]-8-oxo-5-tia-1-aza-biciclo[4.2.0]oct-2-eno-2-carboxilico cristalino; su elaboracion y uso
WO2010030810A1 (en) * 2008-09-10 2010-03-18 Achaogen, Inc. Carbacephem beta-lactam antibiotics
WO2010072672A1 (en) 2008-12-24 2010-07-01 Basilea Pharmaceutica Ag New crystal polymorphs of ceftobiprole
CN101899059B (zh) * 2009-01-21 2012-02-15 山东轩竹医药科技有限公司 含有吡咯烷并环的头孢菌素衍生物
WO2010136423A1 (de) * 2009-05-25 2010-12-02 Sandoz Ag Verfahren zur herstellung von ceftobiprol medocaril
CN102030766B (zh) * 2009-09-30 2012-08-08 山东轩竹医药科技有限公司 含有二氢吡咯并杂环的头孢抗生素
CN103864851B (zh) * 2014-03-25 2016-08-17 华润赛科药业有限责任公司 作为前药的头孢吡普衍生物及其制备方法和用途
WO2024079094A1 (en) 2022-10-10 2024-04-18 Basilea Pharmaceutica International Ag, Allschwil Methods of treating staphylococcus aureus bacteremia infections

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL94946A0 (en) * 1989-07-13 1991-06-10 Eisai Co Ltd 3-substituted vinyl cephalosporin derivatives,their preparation and pharmaceutical compositions containing them
JPH08502513A (ja) * 1992-10-23 1996-03-19 藤沢薬品工業株式会社 セフェム化合物、およびそれらの医薬組成物
US5523400A (en) * 1993-04-16 1996-06-04 Hoffmann-La Roche Inc. Cephalosporin antibiotics
ES2185634T3 (es) * 1993-04-16 2003-05-01 Basilea Pharmaceutica Ag Derivados de cefalosporina.
EP0723965B1 (de) * 1993-09-29 2001-05-30 Meiji Seika Kaisha Ltd. Neue cephalosporinderivate
TR199700859T1 (xx) 1995-02-27 1998-02-21 F. Hoffmann-La Roche Ag 3-Pirolidiliden-2-on-sefalosporin t�revleri.
JPH08319291A (ja) * 1995-05-25 1996-12-03 Meiji Seika Kaisha Ltd 新規セフェム誘導体
AT403161B (de) * 1995-07-19 1997-11-25 Biochemie Gmbh Verfahren zur herstellung von cephemverbindungen

Also Published As

Publication number Publication date
CN1347884A (zh) 2002-05-08
CN1325850A (zh) 2001-12-12
JP4043203B2 (ja) 2008-02-06
CN1183141C (zh) 2005-01-05
ES2179996T3 (es) 2003-02-01
IL122604A0 (en) 1998-08-16
JPH10182657A (ja) 1998-07-07
CA2628224C (en) 2010-02-16
CN1104436C (zh) 2003-04-02
HUP9702474A2 (hu) 1998-11-30
CZ405797A3 (cs) 1998-07-15
HUP9702474A3 (en) 2001-04-28
PT849269E (pt) 2002-11-29
KR100395985B1 (ko) 2004-02-14
NZ329363A (en) 1999-01-28
DE69713865T2 (de) 2003-02-20
DK0849269T3 (da) 2002-10-28
NO975901D0 (no) 1997-12-16
CN1198833C (zh) 2005-04-27
CN1188112A (zh) 1998-07-22
CA2224438A1 (en) 1998-06-19
CN1347882A (zh) 2002-05-08
JP2002060390A (ja) 2002-02-26
EP0849269A1 (de) 1998-06-24
AU4846397A (en) 1998-06-25
AU729653B2 (en) 2001-02-08
CN1347883A (zh) 2002-05-08
CN1163496C (zh) 2004-08-25
HU9702474D0 (en) 1998-03-02
CY2400B1 (en) 2004-09-10
KR19980064240A (ko) 1998-10-07
EP0849269B9 (de) 2003-03-05
JP3264877B2 (ja) 2002-03-11
CA2224438C (en) 2009-02-24
MA26457A1 (fr) 2004-12-20
KR100310384B1 (ko) 2001-11-08
ATE220402T1 (de) 2002-07-15
DE69713865D1 (de) 2002-08-14
KR100331212B1 (ko) 2002-04-03
EP0849269B1 (de) 2002-07-10
US5981519A (en) 1999-11-09
CN1132833C (zh) 2003-12-31
TW415949B (en) 2000-12-21
CA2628224A1 (en) 1998-06-19

Similar Documents

Publication Publication Date Title
NO975901L (no) Vinyl-pyrrolidinon cefalosporiner med basiske substituenter
AU1025795A (en) Prolineamide derivatives
AU5669298A (en) Cyclosporin derivatives, their preparation and pharmaceutical compositions containing them
BG103945A (bg) Производни на 4"-заместен-9-деоксо-9а-аза-9а- хомоеритромицин а
NO20004624D0 (no) Benzensulfonamid-derivater og deres anvendelse som medikamenter
NO331002B1 (no) Tioxantinderivater og farmasoytiske preparater med tioxantinderivater
HUP0001269A2 (hu) 2-Oxo-1-azetidin-szulfonsav-származékok és ezeket tartalmazó kombinált gyógyszerkészítmények
TW375615B (en) Galanthamine derivatives and their use as medicaments
NO911041L (no) Fremgangsmaate for fremstilling av 3-tetrazolyltiometyl-cefalosporinantibiotika.
PT992509E (pt) Novos derivados macrolidos
DE69302646D1 (de) Benzimidazolverbindungen als Antibiotika gegen Campylobacter pylon
MY135646A (en) Indolyl derivatives
NZ332687A (en) use of 1-methyl-carbapenem derivatives as anti-helicobacter pylori agents
HU893127D0 (en) Process for the preparation of novel spiro-(imidazolidino-naphtaline) derivatives and pharmaceutical compositions containing such compounds as active ingredient
AP9801235A0 (en) Erythromycin derivatives.
WO2001017955A3 (en) Hydroxyacetamidobenzenesulphonamide derivatives
NO20013601L (no) Nye morfolinobenzamidsalter
AU1390692A (en) Use of 2-iminothiazolidin-4-one derivatives as novel pharmaceutical active ingredients
DE69429447D1 (de) Verwendung von 2-aminopurinderivaten zur behandlung und prophylaxe der menschlichen herpesvirus 7 infektionen
MXPA99003849A (es) Derivados 9a, 11b-deshidro de 9-oxima-3-ceto-6-0-metileritromicina.
ATE210985T1 (de) Verwendung von 2-aminopurinderivaten zur behandlung und prophylaxe der menschlichen herpesvirus 6 infektionen
SE8900725D0 (sv) Indolfoereningar och framstaellning daerav
YU43797A (en) Vinylpyrrolidone cephalosporin derivatives, process for preparation thereof, pharamceutical preparations containing them and their usage for preparation of medicaments
GEP19980890B (en) Derivatives of N1-(1,2-Cis-halogeno¬-cyclopropyl) Substituted Pyridonecarbonic Acid
KR890001561A (ko) 세균감염 치료용 약제학적 제제

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application